N-Cadherin Dependent Collective Cell Invasion of Prostate Cancer Cells Is Regulated by the N-Terminus of α-Catenin

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Cui, Yuanyuan ^a   Yamada, Soichiro ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; NERVE CELL ADHESION MOLECULE;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; PHENOTYPE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALPHA CATENIN; CADHERINS; CELL LINE, TUMOR; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84872832924     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055069     Document Type: Article

References (40)

1. Valastyan S, Weinberg RA, (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147: 275-292.
2. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR, (2008) Cadherin switching. J Cell Sci 121: 727-735.
3. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA, (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148: 779-790.
4. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ, (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631-644.
5. Suyama K, Shapiro I, Guttman M, Hazan RB, (2002) A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301-314.
6. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, et al. (2007) N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 67: 3106-3116.
7. Chung S, Yao J, Suyama K, Bajaj S, Qian X,et al. (2012) N-cadherin regulates mammary tumor cell migration through Akt3 suppression. Oncogene.
8. Li G, Satyamoorthy K, Herlyn M, (2001) N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61: 3819-3825.
9. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, et al. (2010) Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 16: 1414-1420.
10. Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP,et al. (2012) The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene.
11. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR, (1996) Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 135: 1643-1654.
12. Sanchez-Heras E, Howell FV, Williams G, Doherty P, (2006) The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule. J Biol Chem 281: 35208-35216.
13. Bussemakers MJ, Van Bokhoven A, Tomita K, Jansen CF, Schalken JA, (2000) Complex cadherin expression in human prostate cancer cells. Int J Cancer 85: 446-450.
14. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, et al. (2000) Cadherin switching in human prostate cancer progression. Cancer Res 60: 3650-3654.
15. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA, (2007) A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13: 7003-7011.
16. Ishida E, Nakamura M, Shimada K, Matsuyoshi S, Tada K, et al. (2004) Autopsy case of prostate cancer with multiple endocrine neoplasia 2A. Pathol Int 54: 918-923.
17. Jennbacken K, Tesan T, Wang W, Gustavsson H, Damber JE, et al. (2010) N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer. Endocr Relat Cancer 17: 469-479.
18. Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, et al. (2006) N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 66: 193-199.
19. Pokutta S, Drees F, Takai Y, Nelson WJ, Weis WI, (2002) Biochemical and structural definition of the l-afadin- and actin-binding sites of alpha-catenin. J Biol Chem 277: 18868-18874.
20. Yonemura S, Wada Y, Watanabe T, Nagafuchi A, Shibata M, (2010) alpha-Catenin as a tension transducer that induces adherens junction development. Nat Cell Biol 12: 533-542.
21. le Duc Q, Shi Q, Blonk I, Sonnenberg A, Wang N, et al. (2010) Vinculin potentiates E-cadherin mechanosensing and is recruited to actin-anchored sites within adherens junctions in a myosin II-dependent manner. J Cell Biol 189: 1107-1115.
22. Harma V, Virtanen J, Makela R, Happonen A, Mpindi JP, et al. (2010) A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 5: e10431.
23. Weber GF, Bjerke MA, DeSimone DW, (2012) A mechanoresponsive cadherin-keratin complex directs polarized protrusive behavior and collective cell migration. Dev Cell 22: 104-115.
24. Shih W, Yamada S (2012) N-cadherin-mediated cell-cell adhesion promotes cell migration in a three-dimensional matrix. J Cell Sci.
25. Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ, et al. (2008) Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res 6: 1259-1267.
26. Huang CF, Lira C, Chu K, Bilen MA, Lee YC, et al. (2010) Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res 70: 4580-4589.
27. Tamura D, Hiraga T, Myoui A, Yoshikawa H, Yoneda T, (2008) Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol 33: 17-24.
28. Nakagawa S, Takeichi M, (1995) Neural crest cell-cell adhesion controlled by sequential and subpopulation-specific expression of novel cadherins. Development 121: 1321-1332.
29. Patel IS, Madan P, Getsios S, Bertrand MA, MacCalman CD, (2003) Cadherin switching in ovarian cancer progression. Int J Cancer 106: 172-177.
30. Wong AS, Maines-Bandiera SL, Rosen B, Wheelock MJ, Johnson KR, et al. (1999) Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer 81: 180-188.
31. Carmona FJ, Villanueva A, Vidal A, Munoz C, Puertas S,et al. (2012) Epigenetic Disruption of Cadherin-11 in Human Cancer Metastasis. J Pathol.
32. Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS, (1995) Alpha 1(E)-catenin is an actin-binding and-bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci U S A 92: 8813-8817.
33. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI, (2005) Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 123: 903-915.
34. Aaltomaa S, Karja V, Lipponen P, Isotalo T, Kankkunen JP, et al. (2005) Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancer. Anticancer Res 25: 4707-4712.
35. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Kosma VM, (1999) Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Br J Cancer 80: 477-482.
36. van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, et al. (2007) The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study. Prostate 67: 1432-1438.
37. Richmond PJ, Karayiannakis AJ, Nagafuchi A, Kaisary AV, Pignatelli M, (1997) Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Cancer Res 57: 3189-3193.
38. Morita N, Uemura H, Tsumatani K, Cho M, Hirao Y, et al. (1999) E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion. Br J Cancer 79: 1879-1883.
39. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB, (1993) Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res 53: 3585-3590.
40. Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ, (2005) Deconstructing the cadherin-catenin-actin complex. Cell 123: 889-901.